The CEO and two directors buying shares at current levels near $26 after a strong earnings beat is a rare alignment of insider conviction with positive fundamentals. Monitor for additional insider purchases or a 13D filing. The $83K sale by the SVP & Controller is routine and likely tax-related, ignore it. The cluster amplifies the bullish read from Q2 earnings and suggests management sees the stock as undervalued.
PFE drugs
PFE drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 13 $26.80entry
- T+1 · 3mo ago −0.04%α +0.16% · $26.79
- T+5 · 3mo ago +3.69%α +5.66% · $27.79
- T+20 · 2mo ago +3.43%α +5.18% · $27.72
- T+60 · 10d ago +9.66%α +15.14% · $29.39
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Four Pfizer insiders traded within a week of Q2 2026 earnings. Chairman & CEO Albert Bourla and two directors made open-market purchases totaling ~$2.96M at ~$25.46-$26.34 per share, while SVP & Controller Jennifer Damico sold $83K worth of shares. The insider buying cluster follows a strong Q2 earnings beat (EPS $0.77 vs $0.68 consensus) and raised full-year revenue guidance, suggesting management sees value at current levels despite the stock's recent weakness.
Key Financial Metrics
Key Facts
- CEO Albert Bourla purchased 38,000 shares at $26.34 for $1.00M on 2026-08-12
- Director Ronald Blaylock purchased 39,200 shares at $25.46 for $999K on 2026-08-05
- Director Mortimer Buckley purchased 37,600 shares at $25.52 for $960K on 2026-08-05
- SVP & Controller Jennifer Damico sold 3,300 shares at $25.40 for $83K on 2026-08-05
- Total open-market purchases by C-suite and directors: $2.96M
- Total insider buying represents ~0.002% of $151.7B market cap, trivial in absolute proportion but significant as a conviction signal from top executives
- Q2 2026 earnings beat consensus by 12.9% on EPS and 4.5% on revenue, with raised full-year guidance
- Stock trades at $26.36, near the purchase prices of all three buying insiders
Financial Impact
Insider purchases of $2.96M at ~$25.46-$26.34 per share represent a strong vote of confidence from the CEO and two directors following a Q2 earnings beat and raised guidance
Risk Factors
- Insider purchases are small relative to $151.7B market cap, not a liquidity signal
- Pfizer faces ongoing patent cliffs on key products and $4.3B in non-cash impairments from Q2
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PFE-1786565122998 |
Track record
21 reports on PFE
4 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +17.28% at T+60 after the Aug 4, 2026 report. 6 of 8 went positive at some point.
Filters
- Nov 3, 202612d ago 8-K Neutral 2/10 Entry $30.79 Now $28.92 −6.09% settles Feb 2
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $30.00 Now $28.92 −3.62% settles Feb 1
- Oct 30, 202617d ago Court Ruling Neutral 2/10 Entry $30.67 Now $28.92 −5.72% settles Jan 29
- Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $30.03 Now $28.92 −3.71% settles Jan 21
- Aug 13, 202613w ago Court Ruling Neutral 1/10 Entry $26.79 to $29.23 Now $28.92 +7.93% ▲ +9.11% +12.15% vs SPY
- Aug 12, 202613w ago Insider Buy Bullish 5/10 Entry $26.80 to $29.39 Now $28.92 +7.89% ▲ +9.66% +15.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Bullish 6/10 Viewing Entry $26.80 to $29.39 Now $28.92 +7.89% ▲ +9.66% +15.14% vs SPY
- Aug 6, 202614w ago Insider Cluster Bullish 4/10 Entry $26.20 to $30.52 Now $28.92 +10.36% ▲ +16.49% +18.16% vs SPY
- Aug 5, 202614w ago Insider Buy Bullish 5/10 Entry $26.20 to $30.52 Now $28.92 +10.36% ▲ +16.49% +18.16% vs SPY
- Aug 5, 202614w ago Insider Cluster Neutral 3/10 Entry $26.20 to $30.52 Now $28.92 +10.36% ▲ +16.49% +18.16% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers